Beatrice Savastano
Pagani, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma.
Journal: Frontiers in oncology
Published: July 03, 2020
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature.
Journal: Critical reviews in oncology/hematology
Published: April 15, 2020
Coronavirus Disease 2019 Emergency and Cancer in the South of Italy: What's New for the Oncologist?
Journal: Frontiers in medicine
Published: April 10, 2020
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients.
Journal: Journal of gastrointestinal oncology
Published: April 30, 2019
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis.
Journal: Gastroenterology research and practice
Published: February 26, 2018
Pancreatic neuroendocrine tumors: Nosography, management and treatment.
Journal: International journal of surgery (London, England)
Published: April 10, 2015
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.
Journal: BMC cancer
Published: March 04, 2015
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report.
Journal: Oncology letters
Published: February 15, 2014
Clinical management of advanced gastric cancer: the role of new molecular drugs.
Journal: World journal of gastroenterology
Published: October 29, 2013
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer.
Journal: Current oncology (Toronto, Ont.)
Published: August 02, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026